Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Invested Capital: 2023-2025

Historic Return on Invested Capital for GeneDx Holdings (WGS) over the last 2 years, with Sep 2025 value amounting to 0.02%.

  • GeneDx Holdings' Return on Invested Capital rose 25.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 25.00%. This contributed to the annual value of -0.10% for FY2024, which is 63.00% up from last year.
  • Per GeneDx Holdings' latest filing, its Return on Invested Capital stood at 0.02% for Q3 2025, which was up 58.02% from 0.02% recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Return on Invested Capital peaked at 0.02% during Q3 2025, and registered a low of -1.97% during Q1 2023.
  • Moreover, its 3-year median value for Return on Invested Capital was -0.45% (2024), whereas its average is -0.72%.
  • Data for GeneDx Holdings' Return on Invested Capital shows a peak YoY spiked of 148bps (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows GeneDx Holdings' Return on Invested Capital stood at -0.73% in 2023, then soared by 64bps to -0.09% in 2024, then climbed by 25bps to 0.02% in 2025.
  • Its Return on Invested Capital stands at 0.02% for Q3 2025, versus 0.02% for Q2 2025 and -0.09% for Q4 2024.